Multidisciplinary Tumour Board
South Hall 2
South Hall 2
Date
Thu, 31.03.2022
Time
11:15 - 12:45
Chairs
- Keith M. Kerr, Aberdeen, GB
Location
South Hall 2
More targets, more drugs, more choices, more conflicts
Multidisciplinary Tumour Board
Case presentation - A patient with ALK+ NSCLC: How clinical characteristics, biopsy specimen and cfDNA can guide treatment decisions (ID 59)
Speakers
- Laura Mezquita, Barcelona, ES
Room
South Hall 2
Date
Thu, 31.03.2022
Time
11:15 - 12:45
Duration
10 Minutes
Lecture Time
11:15 - 11:25
More targets, more drugs, more choices, more conflicts
Multidisciplinary Tumour Board
Integrated testing: The challenges we now face (ID 60)
Speakers
- Keith M. Kerr, Aberdeen, GB
Room
South Hall 2
Date
Thu, 31.03.2022
Time
11:15 - 12:45
Duration
15 Minutes
Lecture Time
11:25 - 11:40
More targets, more drugs, more choices, more conflicts
Multidisciplinary Tumour Board
Targeted therapy and immunotherapy: Can the patient have both? (ID 61)
Speakers
- Anne-Marie C. Dingemans, Rotterdam, NL
Room
South Hall 2
Date
Thu, 31.03.2022
Time
11:15 - 12:45
Duration
15 Minutes
Lecture Time
11:40 - 11:55
More targets, more drugs, more choices, more conflicts
Multidisciplinary Tumour Board
Co-mutations: Impact on current treatments and new combinations (ID 62)
Speakers
- Pilar Garrido Lopez, Madrid, ES
Room
South Hall 2
Date
Thu, 31.03.2022
Time
11:15 - 12:45
Duration
15 Minutes
Lecture Time
11:55 - 12:10
More targets, more drugs, more choices, more conflicts
Multidisciplinary Tumour Board
Rebiopsy and cfDNA in a complex and changing landscape (ID 63)
Speakers
- Nicola Normanno, Napoli, IT
Room
South Hall 2
Date
Thu, 31.03.2022
Time
11:15 - 12:45
Duration
15 Minutes
Lecture Time
12:10 - 12:25
More targets, more drugs, more choices, more conflicts
Multidisciplinary Tumour Board
Discussion (ID 64)
Room
South Hall 2
Date
Thu, 31.03.2022
Time
11:15 - 12:45
Duration
20 Minutes
Lecture Time
12:25 - 12:45